Rapid7 (RPD) shares rallied 3.6% within the final buying and selling session to shut at $107.13. This transfer could be attributable to notable quantity with a better variety of shares being traded than in a typical session. This compares to the inventory’s 8.6% acquire over the previous 4 weeks.
The upswing in share worth got here after the corporate introduced it has acquired IntSights Cyber Intelligence, a frontrunner in contextualized exterior menace intelligence and proactive menace remediation, for $335 million in money and inventory.
With the acquisition of IntSights, Rapid7 will mix its current menace intelligence applied sciences with IntSights’ menace detection and remediation capabilities in a single buyer providing. This acquisition additionally enhances Rapid7’s industry-leading cloud-native prolonged detection and response (XDR) providing, InsightIDR, by enabling high-quality, high-fidelity alerts to make sure environment friendly safety operations, earlier menace detection, and accelerated response instances.
This cybersecurity firm is anticipated to put up quarterly earnings of $0.03 per share in its upcoming report, which represents a year-over-year change of -40%. Revenues are anticipated to be $122.73 million, up 24.1% from the year-ago quarter.
Earnings and income development expectations definitely give a very good sense of the potential power in a inventory, however empirical analysis reveals that developments in earnings estimate revisions are strongly correlated with near-term inventory worth actions.
For Rapid7, the consensus EPS estimate for the quarter has remained unchanged over the past 30 days. And a inventory’s worth often would not hold transferring increased within the absence of any development in earnings estimate revisions. So, be certain that to control RPD going ahead to see if this latest leap can flip into extra power down the street.
The inventory at present carries a Zacks Rank 3 (Maintain). You may see the entire checklist of at this time’s Zacks Rank #1 (Robust Purchase) shares right here >>>>
Breakout Biotech Shares with Triple-Digit Revenue Potential
The biotech sector is projected to surge past $775 billion by 2024 as scientists develop therapies for hundreds of ailments. They’re additionally discovering methods to edit the human genome to actually erase our vulnerability to those ailments.
Zacks has simply launched Century of Biology: 7 Biotech Shares to Purchase Proper Now to assist buyers revenue from 7 shares poised for outperformance. Our latest biotech suggestions have produced positive aspects of +50%, +83% and +164% in as little as 2 months. The shares on this report may carry out even higher.
See these 7 breakthrough shares now>>
Click on to get this free report
Rapid7, Inc. (RPD): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.